A Comparative Evaluation of TEG Versus ROTEM for Coagulopathy Correction
A Comparative Evaluation of Thromboelastography Versus Thromboelastometry for Coagulopathy Correction in Patients of Liver Cirrhosis With Non Variceal Bleed- Prospective Observational Study
1 other identifier
observational
60
1 country
1
Brief Summary
Studies comparing Thromboelastography or Rotational thromboelastometry versus standard coagulation tests are abundant. Data comparing the two exclusively in a liver intensive care set up is limited. Studies show that TEG and ROTEM cannot be used interchangeably in trauma, liver transplant patients, but there is limited evidence of the same in critically ill cirrhotic patients. In this study, the investigators tried to demonstrate the comparison of blood products used to treat coagulopathy based on TEG versus ROTEM algorithms in cirrhotic patients presenting with non variceal bleeding
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2022
CompletedFirst Submitted
Initial submission to the registry
January 13, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedApril 19, 2022
January 1, 2022
6 months
January 13, 2022
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total amount of blood products transfused at 8 hours(FFP, Cryoprecipitate, platelets) will be measured
Total amount of blood products transfused at 8 hours(FFP, Cryoprecipitate, platelets) will be measured
8 hours
Secondary Outcomes (10)
R time of thromboelastography
8 hours
K time of thromboelastography
8 hours
alpha angle of thromboelastography
8 hours
Maximum amplitude of thromboleastography
8 hours
LY30 Iin thromboelastometry
8 hours
- +5 more secondary outcomes
Study Arms (2)
TEG group
Thromboelastography guided blood product administration in patients of liver cirrhosis with non variceal bleed
ROTEM group
Throboelastometry guided blood product administration in patients of liver cirrhosis with non variceal bleed
Eligibility Criteria
patients of liver cirrhosis who are presenting with non variceal bleed would be included in this study
You may qualify if:
- patients of liver cirrhosis with non variceal bleed
You may not qualify if:
- Pregnant and postpartum patients
- died within the first 24hours of admission.
- variceal and postvariceal ligation ulcer bleed.
- On anticoagulants or antiplatelets at the time of admission in ICU
- Transfusion with blood products before admission to the ICU.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
Related Publications (4)
Premkumar M, Saxena P, Rangegowda D, Baweja S, Mirza R, Jain P, Bhatia P, Kumar G, Bihari C, Kalal C, Vyas T, Choudhury A, Sarin SK. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int. 2019 Apr;39(4):694-704. doi: 10.1111/liv.14034. Epub 2019 Feb 7.
PMID: 30589495BACKGROUNDKumar M, Ahmad J, Maiwall R, Choudhury A, Bajpai M, Mitra LG, Saluja V, Mohan Agarwal P, Bihari C, Shasthry SM, Jindal A, Bhardwaj A, Kumar G, Sarin SK. Thromboelastography-Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial. Hepatology. 2020 Jan;71(1):235-246. doi: 10.1002/hep.30794. Epub 2019 Aug 27.
PMID: 31148204BACKGROUNDWikkelso A, Wetterslev J, Moller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD007871. doi: 10.1002/14651858.CD007871.pub3.
PMID: 27552162BACKGROUNDSingh SA, Krishnan G, Ashraf H, Subramanian R, Pandey V, Nasa VK, Goyal S, Gupta S. Correlation between thromboelastography and rotational thromboelastometry values in adult liver transplant recipients. Indian J Anaesth. 2020 Apr;64(4):286-291. doi: 10.4103/ija.IJA_762_19. Epub 2020 Mar 28.
PMID: 32489202BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
NIMI GOPAL
Institute of Liver and Biliary Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2022
First Posted
April 19, 2022
Study Start
July 1, 2021
Primary Completion
January 8, 2022
Study Completion
January 8, 2022
Last Updated
April 19, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share